Codes ATC:
C01EA01
EMLc
Indication
Other specified congenital anomaly of great arteries including arterial duct
Code ICD11:
LA8C.Y
INN
Alprostadil
Type de médicament
Chemical agent
Type de liste
Liste complémentaire
(EML)
(EMLc)
(EMLc)
Formulations
Parenteral > General injections > IV:
0.5 mg per mL in alcohol
(EMLc)
Historique des statuts LME
Sexe
Tous
Âge
Nouveau-né (< 1 mois)
Équivalence thérapeutique
dinoprostone (prostaglandin E2)
(Codes ATC: G02AD02)
Parenteral > General injections > IV: 1 mg per mL
Parenteral > General injections > IV: 1 mg per mL
Renseignements sur le brevet
Patents have expired in most jurisdictions
Lire la suite
sur les brevets.
Wikipédia
DrugBank
Résumé des preuves et recommandation du comité d'experts
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended updating the medicine descriptions for prostaglandin E1 and E2 to reflect active ingredients by international non-proprietary names (alprostadil and dinoprostone).